Influence of BDNF and COMT polymorphisms on emotional decision making

Neuropharmacology

Volumn 58, Issue 7, 2010, Pages 1109-1113

  Kang, Jee In ^a,b   Namkoong, Kee ^a   Ha, Ra Yeon ^a   Jhung, Kyungun ^a   Kim, Yang Tae ^c   Kim, Se Joo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Bugok National Hospital   (South Korea)

Author keywords

BDNF Val66Met; COMT Val158Met; Emotional decision making; Iowa gambling task

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BRAIN FUNCTION; COLLEGE STUDENT; DECISION MAKING; EMOTIONALITY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; DECISION MAKING; EMOTIONS; FEMALE; GAMBLING; GENOTYPE; HUMANS; KOREA; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 77950949475     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.02.001     Document Type: Article

References (35)

1. Bechara A., Damasio H., Damasio A.R. Manipulation of dopamine and serotonin causes different effects on covert and overt decision making. Society for Neuroscience Abstracts 2001, 465:5.
2. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science 1997, 275:1293-1295.
3. Bechara A., Martin E.M. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 2004, 18:152-162.
4. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
5. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition. Neuroscience 2009, 10.1016/j.neuroscience.2009.12.022.
6. Brand M., Labudda K., Markowitsch H.J. Neuropsychological correlates of decision-making in ambiguous and risky situations. Neural Networks 2006, 19:1266-1276.
7. Brand M., Recknor E.C., Grabenhorst F., Bechara A. Decisions under ambiguity and decisions under risk: correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules. Journal of Clinical and Experimental Neuropsychology 2007, 29:86-99.
8. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biological Psychiatry 2006, 59:812-815.
9. Buelow M.T., Suhr J.A. Construct validity of the Iowa gambling task. Neuropsychological Review 2009, 19:102-114.
10. Chen Z.Y., Bath K., McEwen B., Hempstead B., Lee F. Impact of genetic variant BDNF (Val66Met) on brain structure and function. Novartis Foundation Symposium 2008, 289:180-188.
11. Deltheil T., Guiard B.P., Guilloux J.P., Nicolas L., Delomenie C., Reperant C., Le Maitre E., Leroux-Nicollet I., Benmansour S., Coudore F., David D.J., Gardier A.M. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacology, Biochemistry, and Behavior 2008, 90:174-183.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV) 1997, American Psychatric Press, Washington, DC.
13. Gasic G.P., Smoller J.W., Perlis R.H., Sun M., Lee S., Kim B.W., Lee M.J., Holt D.J., Blood A.J., Makris N., Kennedy D.K., Hoge R.D., Calhoun J., Fava M., Gusella J.F., Breiter H.C. BDNF, relative preference, and reward circuitry responses to emotional communication. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2009, 150B:762-781.
14. Gong P., Zheng A., Chen D., Ge W., Lv C., Zhang K., Gao X., Zhang F. Effect of BDNF Val66Met polymorphism on digital working memory and spatial localization in a healthy Chinese Han population. Journal of Molecular Neuroscience 2009, 38:250-256.
15. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 2007, 61:911-922.
16. Ha R.Y., Namkoong K., Kang J.I., Kim Y.T., Kim S.J. Interaction between serotonin transporter promoter and dopamine receptor D4 polymorphisms on decision making. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33:1217-1222.
17. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 2003, 23:6690-6694.
18. Hashimoto R., Moriguchi Y., Yamashita F., Mori T., Nemoto K., Okada T., Hori H., Noguchi H., Kunugi H., Ohnishi T. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neuroscience Research 2008, 61:360-367.
19. Hemmings S.M., Kinnear C.J., Van der Merwe L., Lochner C., Corfield V.A., Moolman-Smook J.C., Stein D.J. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World Journal of Biological Psychiatry 2008, 9:126-134.
20. Kim B., Kim C.Y., Hong J.P., Kim S.Y., Lee C., Joo Y.H. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008, 58:97-103.
21. Kim Y.R., Kim J.H., Kim S.J., Lee D., Min S.K. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population. European Neuropsychopharmacology 2008, 18:820-825.
22. Kim Y.T., Lee S.J., Kim S.H. Effects of the history of conduct disorder on the Iowa gambling tasks. Alcoholism, Clinical and Experimental Research 2006, 30:466-472.
23. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
24. Lee Y., Kim Y.T., Seo E., Park O., Jeong S.H., Kim S.H., Lee S.J. Dissociation of emotional decision-making from cognitive decision-making in chronic schizophrenia. Psychiatry Research 2007, 152:113-120.
25. Lu B. BDNF and activity-dependent synaptic modulation. Learning & Memory 2003, 10:86-98.
26. Maia T.V., McClelland J.L. A reexamination of the evidence for the somatic marker hypothesis: what participants really know in the Iowa gambling task. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:16075-16080.
27. McHughen S.A., Rodriguez P.F., Kleim J.A., Kleim E.D., Crespo L.M., Procaccio V., Cramer S.C. BDNF Val66Met polymorphism influences motor system function in the human brain. Cerebral Cortex 2009, 10.1093/cercor/bhp189.
28. Monteleone P., Zanardini R., Tortorella A., Gennarelli M., Castaldo E., Canestrelli B., Maj M. The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder. Neuroscience Letters 2006, 406:133-137.
29. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 2004, 24:10099-10102.
30. Rogers R.D., Tunbridge E.M., Bhagwagar Z., Drevets W.C., Sahakian B.J., Carter C.S. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 2003, 28:153-162.
31. Roussos P., Giakoumaki S.G., Pavlakis S., Bitsios P. Planning, decision-making and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 2008, 46:757-763.
32. Rybakowski J.K., Borkowska A., Czerski P.M., Skibinska M., Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disorders 2003, 5:468-472.
33. Sheldrick A.J., Krug A., Markov V., Leube D., Michel T.M., Zerres K., Eggermann T., Kircher T. Effect of COMT val158met genotype on cognition and personality. European Psychiatry 2008, 23:385-389.
34. van den Bos R., Homberg J., Gijsbers E., den Heijer E., Cuppen E. The effect of COMT Val158Met genotype on decision-making and preliminary findings on its interaction with the 5-HTTLPR in healthy females. Neuropharmacology 2009, 56:493-498.
35. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Science 2002, 70:735-744.